Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph early_phase_1
1
13%
Ph phase_2
1
13%
Ph phase_3
1
13%
Ph phase_1
1
13%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

completed563%
unknown338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8